WOONSOCKET, R.I. — CVS Health’s fourth quarter sales and earnings beat Wall Street’s expectations, as demand for COVID-19 tests and vaccines drove customers to stores. Revenue for the three months ended December 31 jumped 10.1% from a year earlier to $76.6 billion, topping analysts’ projection of $75.67 billion. Adjusted earnings per share climbed 52% to
WOONSOCKET, R.I. —At their 2021 Investor Day on Thursday, the CVS Health leadership team rolled out their strategy that looks to capitalize on the significant opportunity to make health care more convenient, personalized and affordable for consumers. Company leaders were showing how investing in high-growth areas of the business and introducing new health products, services
WOONSOCKET, R.I. — CVS Health beat Wall Street’s projections for third quarter sales and earnings, and again lifted its full-year guidance as store traffic rose for prescriptions and COVID-19 shots. Adjusted earnings per share for the three months ended September 30 jumped 18.7% from a year earlier to $1.97, topping the average analyst prediction of
WOONSOCKET, R.I.— CVS Health announced this week that it will require certain employees who interact with patients to be fully vaccinated for COVID-19 by October 31, 2021. The company will also require all corporate staff to be fully vaccinated no later than October 31. New hires in the same roles as of September 15 must
WOONSOCKET, R.I. — CVS Health announced that COVID-19 vaccine appointments for adolescents ages 12 to 15 are now available for scheduling at more than 5,600 CVS Pharmacy locations nationwide, following Food and Drug Administration (FDA) Emergency Use Authorization of the Pfizer-BioNTech vaccine for this age group. Starting tomorrow, May 13, participating CVS Pharmacy locations will
WOONSOCKET, R.I. — CVS Health has launched CVS Health Ventures, a dedicated corporate venture capital fund that will invest in and partner with high-potential, early-stage companies focused on making health care more accessible, affordable, and simpler. “Consumers deserve a better health experience, one that puts them at the center of cutting-edge, digitally enabled solutions,” said Karen
The chain drug industry has yet to meet Karen Lynch. But that’s about to change — for the better. In an industry that has made its considerable reputation, at least in part, on the strength of its leaders, Lynch is both a logical extension of that reputation and a pleasant surprise for those who have
